Colleen F Reitan Myriad Genetics Inc (MYGN) insider trading activity

MYGN Quotes by TradingView

Colleen F Reitan is Director of MYRIAD GENETICS INC. Currently has a direct ownership of 92,329 shares of MYGN, which is worth approximately $423,790. The most recent transaction as insider was on Jun 05, 2025, when has been sold 49,796 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 92.3K
117.08% 3M change
4.27% 12M change
Total Value Held $423,790

Colleen F Reitan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2025
BUY
Grant, award, or other acquisition
-
49,796 Added 35.04%
92,329 Common Stock
Sep 03 2024
SELL
Open market or private sale
$1,286,035 $27.95 p/Share
46,012 Reduced 51.96%
42,533 Common Stock
Jun 06 2024
BUY
Grant, award, or other acquisition
-
15,695 Added 15.06%
88,545 Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
-
15,151 Added 17.22%
72,850 Common Stock
Jun 02 2022
BUY
Grant, award, or other acquisition
-
17,275 Added 23.04%
57,699 Common Stock
Jun 03 2021
BUY
Grant, award, or other acquisition
-
12,848 Added 24.12%
40,424 Common Stock
Dec 04 2020
BUY
Grant, award, or other acquisition
-
15,889 Added 36.56%
27,576 Common Stock

Also insider at

ALNY
ALNYLAM PHARMACEUTICALS, INC. Healthcare
Director
CFR

Colleen F Reitan

Director
Cambridge, MA

Track Institutional and Insider Activities on MYGN

Follow MYRIAD GENETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYGN shares.

Notify only if

Insider Trading

Get notified when an Myriad Genetics Inc insider buys or sells MYGN shares.

Notify only if

News

Receive news related to MYRIAD GENETICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MYGN